Processing

Please wait...

Settings

Settings

Goto Application

1. WO2010030824 - GELATINOUS ELASTOMER COMPOSITIONS

Publication Number WO/2010/030824
Publication Date 18.03.2010
International Application No. PCT/US2009/056571
International Filing Date 10.09.2009
IPC
B32B 27/00 2006.1
BPERFORMING OPERATIONS; TRANSPORTING
32LAYERED PRODUCTS
BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
27Layered products essentially comprising synthetic resin
CPC
A61K 31/045
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
A61K 31/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
A61K 31/232
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
22of acyclic acids, e.g. pravastatin
23of acids having a carboxyl group bound to a chain of seven or more carbon atoms
232having three or more double bonds, e.g. etretinate
A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 31/60
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
60Salicylic acid; Derivatives thereof
A61K 47/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
08containing oxygen, ; e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Applicants
  • SILIPOS, INC. [US]/[US] (AllExceptUS)
  • MATTELIANO, Charles J. (UsOnly)
  • SCHAFFER, Stephen P. (UsOnly)
  • SUTTON, Stephen, P. (UsOnly)
Inventors
  • MATTELIANO, Charles J.
  • SCHAFFER, Stephen P.
  • SUTTON, Stephen, P.
Agents
  • HANFT, James, E.
Priority Data
61/095,94110.09.2008US
61/171,68322.04.2009US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) GELATINOUS ELASTOMER COMPOSITIONS
(FR) COMPOSITIONS GÉLATINEUSES D'ÉLASTOMÈRE
Abstract
(EN) The present invention is directed to gelatinous elastomer compositions that are useful for topical application of biologically active agents. In certain embodiments, the invention is directed to a gelatinous elastomer composition comprising about 1.0% to 50.0% block copolymer, about 0% to 98% mineral and/or synthetic oil, and about 0.0% to 98% triglyceride oil, about 0- 15.0% free fatty acids, about 0-30% of a tack modification agent, about 0-20.0% of a biologically active agent and, optionally a phytosterol, ceramide and/or bisabolol. The gelatinous elastomer compositions are useful for applying a biologically active agent to a mammal. In certain embodiments, the gelatinous elastomer composition is formed into a molded article.
(FR) La présente invention porte sur des compositions gélatineuses d'élastomère qui sont utiles pour l'application topique d'agents biologiquement actifs. Dans certains modes de réalisation, l'invention porte sur une composition gélatineuse d'élastomère comprenant environ 1,0 % à 50,0 % de copolymère séquencé, environ 0 % à 98 % d'huile minérale et/ou synthétique et environ 0,0 % à 98 % d'huile triglycéridique, environ 0 à 15,0 % d'acides gras libres, environ 0 à 30 % d'un modificateur de pégosité, environ 0 à 20,0 % d'un agent biologiquement actif et, facultativement, un phytostérol, un céramide et/ou du bisabolol. Les compositions gélatineuses d'élastomère sont utiles pour l'application d'un agent biologiquement actif à un mammifère. Dans certains modes de réalisation, un article moulé est formé avec la composition gélatineuse d'élastomère.
Latest bibliographic data on file with the International Bureau